Corporate
Senior Officers
Joseph Lanfreschi, Ph.D., VP of Laboratory & Clinical Trials Operations
jlanfreschi@pathwaydx.com
Dr. Lanfreschi possesses over 20 years of extensive experience directing domestic and global laboratory operations while supporting pharmaceutical and biotech clinical trials. Prior to Pathway Diagnostics, Dr. Lanfreschi was Managing Director for Quest Diagnostics clinical trials where he drove client satisfaction through increasing efficiencies and quality assurance during a high-growth period. Prior to Quest, Dr. Lanfreschi served as Director of Clinical Trial Services for Quintiles Laboratories where he led a team during a significant growth period that included strategic international acquisitions and partnerships. Prior to Quintiles, Dr. Lanfreschi served in various laboratory leadership roles at Laboratory Corporation of America and Smith Kline Beecham. Dr. Lanfreschi received a Ph.D. from Saint Johns University New York in Pharmacology and Toxicology and his Masters Degree from Long Island University New York in Medical Technology and Clinical Chemistry.
RETURN TO TOP
Terry Robins, Ph.D., VP of Research & Development
trobins@pathwaydx.com
Dr. Robins has over 25 years of experience in area of specialized clinical diagnostics. Prior to joining Pathway Diagnostics, Dr. Robins held the position of Chief Scientific Liaison for Focus Diagnostics, where he directed the development of numerous clinical trial specific diagnostic assays primarily in the areas of immunology, molecular biology and vaccine response. He has also held positions as Assistant Vice-President of Operations at Specialty Laboratories and Virology Group leader at Abbott Laboratories. His work at Abbott Laboratories lead directly to the successful research, development and commercialization of the HIV protease inhibitor drug Ritonavir. Dr. Robins received his Ph.D. in Molecular Biology from UC Berkeley studying cellular oncogenes.
RETURN TO TOP
Stephanie H. Astrow, Ph.D., MBA, VP, Director of Oncology
sastrow@pathwaydx.com
Before joining Pathway Diagnostics, Dr. Astrow was Vice President and Scientific Director of IMPATH Predictive Oncology, where she directed operations focused on providing biological, technological and medical information for the discovery, development and commercialization of next-generation cancer diagnostics and therapeutics. Prior to IMPATH, Dr. Astrow was a faculty member in the Department of Biological Sciences at the University of Southern California. She also directed the operations of the Immunopathology Laboratory at Cedars-Sinai Medical Center. Dr. Astrow holds a Ph.D. from UC Berkeley and an MBA from Pepperdine University.
RETURN TO TOP
Allen R. Gehrke, National Sales Director, Clinical Trials
agehrke@pathwaydx.com
Mr. Gehrke has 25 years of experience in sales, and sales management. For the last 15 years, Mr. Gehrke has been involved in business development for clinical trials industry for both central laboratories and contract research organizations (CRO's). Prior to joining Pathway Diagnostics, he was Executive Director of Business Development for Research Point, a full service CRO. He has also held positions at Quintiles as Executive Director of Business where he was responsible for managing the sales team of the 50 pharmaceutical companies, and Vice President of Business Development for Quintiles Central Laboratories.
RETURN TO TOP
|
